Opening Keynote - Dr. E. John Wherry, PhD; University of Pennsylvania
Dr. E. John Wherry is the Richard and Barbara Schiffrin President’s Distinguished Professor in the Department of Microbiology at the Perelman School of Medicine, Chair of the Department of Systems Pharmacology and Translational Therapeutics (SPATT), and Co-Director of the Parker Institute for Cancer Immunotherapy at Penn. Dr. Wherry’s research focuses on T cell immunity to persisting infections and cancer. In particular, his laboratory has been at the forefront of defining the cellular and molecular mechanisms of T cell exhaustion, a state of immune dysfunction that occurs during chronic infections and cancer.
Closing Keynote - Dr. Christos Sotiriou; Institut Jules Bordet
Dr. Christos Sotiriou is Director of the JC Heuson Laboratory for Translational Research in Breast Cancer at the Jules Bordet Institute, elected member of the European Academy of Cancer Sciences and elected member of the Scientific Council of the International Agency for Research on Cancer of the World Health Organization. Dr Sotiriou is one of the most productive and influential scientists in translational research today. Dr Sotiriou has developed the Genomic Grade Index, a prognostic signature of gene expression being evaluated in a prospective clinical trial in Europe. Dr Sotiriou is currently applying next-generation sequencing technology to answer several important clinical and biological questions that remain unresolved.
The ‘Réseau de la recherche sur le cancer FRQS’, in partnership with the Quebec Node of the Terry Fox Research Institute (TFRI) and the Quebec Cancer Consortium (QCC), welcomes you to its annual meeting!
For this edition, the conference will be split into two half-days: February 15th AM (8:00 a.m. - 12:30 p.m.) and February 16th PM (12 p.m. - 3:15 p.m.) 2021, and will be entirely virtual (on this platform).
The conference will include four synchronous sessions on each of the following major themes:
- Clinical and Translational Research
- Signaling, epigenetics and metabolism
- Targeted therapies and Immunotherapies
- Multi-omics and macro/microenvironmental factors
Once again, we are offering students, medical residents and post-doctoral fellows the opportunity to present their work through poster presentations. In order to submit an abstract, you must be a student member of RRCancer. If you are not yet a member, please complete the appropriate form on the RRCancer website.
- To enable the development and training of students, post-doctoral fellows, medical residents by allowing them to present their research in a poster presentations format.
- To promote scientific exchanges and the establishment of collaborations.
- To inform members about the major ongoing structuring projects in oncology via pre-recorded video clips;
- To maximize interactions between new researchers and other members of the Network by giving them opportunity to showcase their research interests via pre-recorded video clips;
- To allow participants to exchange with prominent international researchers.
This conference would not have been possible without the contribution of each member of the organizing committee chaired by Dr. John Stagg: Dr. Adriana Aguilaar, Maxime Cahuzac, Dr. Kaoutar Ennour-Idrissi, Raul Flores Gonzalez, Dr. Anne-Marie Fortier, Juliet Guay, Kayla Heney, Dr Luisa Izzi, Dr Valérie Janelle, Dr David Labbé, Dr .Camille Lafront, Dr. Jean-Yves Masson, Dr. Anne-Marie Mes-Masson, Dr. Véronique Ouellet, Sarah Saoudaoui, Daméhan Tchelougou, Dr Karine Tremblay, Amélia Walker, Dr Yifan Wang, Dr Ian Watson.
This event is sponsored by the Réseau de recherche sur le cancer, a thematic network supported by the Fonds de recherche du Québec-Santé, the Quebec Node of the Terry Fox Research Institute as well as by the Quebec Cancer Consortium, an initiative funded by the Ministère de l’Économie et de l’Innovation du Québec. Many thanks to these three organizations who allow us to attend this virtual event free of charge.
We wish you all an excellent conference. Let it be as rewarding and interactive as you want it to be!
If you have any questions, please contact email@example.com .